Johnson & Johnson
JNJ
#17
Rank
ยฃ441.96 B
Marketcap
ยฃ183.40
Share price
-0.13%
Change (1 day)
45.20%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2025 (TTM): ยฃ70.32 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is ยฃ70.76 Billion. a decrease over the revenue in the year 2024 that were of ยฃ70.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ69.94 B-1.18%
2024 ยฃ70.77 B5.89%
2023 ยฃ66.84 B-11.28%
2022 ยฃ75.34 B8.45%
2021 ยฃ69.47 B14.66%
2020 ยฃ60.58 B-3.18%
2019 ยฃ62.57 B-2.63%
2018 ยฃ64.26 B13.62%
2017 ยฃ56.56 B-2.91%
2016 ยฃ58.26 B23.21%
2015 ยฃ47.28 B-0.96%
2014 ยฃ47.74 B10.43%
2013 ยฃ43.23 B3.94%
2012 ยฃ41.59 B-0.59%
2011 ยฃ41.83 B4.87%
2010 ยฃ39.89 B4.3%
2009 ยฃ38.25 B-12.06%
2008 ยฃ43.49 B41.43%
2007 ยฃ30.75 B12.97%
2006 ยฃ27.22 B-7.06%
2005 ยฃ29.29 B18.77%
2004 ยฃ24.66 B5.39%
2003 ยฃ23.40 B3.37%
2002 ยฃ22.63 B1.01%
2001 ยฃ22.41 B13.25%
2000 ยฃ19.78 B14.92%
1999 ยฃ17.21 B21.03%
1998 ยฃ14.22 B3.28%
1997 ยฃ13.77 B9.1%
1996 ยฃ12.62 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
ยฃ42.57 B-39.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ47.01 B-33.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ33.30 B-52.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
ยฃ26.65 B-62.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
ยฃ48.96 B-30.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ40.50 B-42.75%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
ยฃ22.11 B-68.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
ยฃ18.86 B-73.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.83 B-30.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ32.88 B-53.53%๐Ÿ‡ฌ๐Ÿ‡ง UK